Green Cross to conduct clinical trial for novel immunotherapy

Published: 2010-03-24 06:57:00

Updated: 2010-03-24 06:57:00

Patients with lymphoma can rest assured that science and technology are finding their way to improving options in cancer care using the body's immune system through the field of immunology.

Green Cross Corporation said on March 22 that it has received an approval from the Korea Food and Drug A...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK